Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-Blind Clinical Trials

Angela Moore; Suzanne Bruce; Neil Sadick; Eduardo Tschen; Philip Werschler; Sunil Dhawan; Douglas Farsha; Michael Gold; Scott Guenthner; Steve Kempers; Leon Kircik; Jennifer Parish; Marta Rendon; Phoebe Rich; Linda Stein-Gold; Stephen Tyring; Robert Weiss; Adnan Nasir; Carsten Schmitz; Terry Boodhoo; Alexandre Kaoukhov; David Berk; Fran Cook-Bolden; Ayman Grada

doi:10.25251/skin.4.supp.51

Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-Blind Clinical Trials

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.4.supp.51 ◽

2020 ◽

Vol 4 (5) ◽

pp. s52

Author(s):

Angela Moore ◽

Suzanne Bruce ◽

Neil Sadick ◽

Eduardo Tschen ◽

Philip Werschler ◽

...

Keyword(s):

Clinical Trials ◽

Acne Vulgaris ◽

Phase 3 ◽

Double Blind ◽

Once Daily ◽

Severe Acne

Abstract not available.

Download Full-text

Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials

Journal of Drugs in Dermatology ◽

10.36849/jdd.2020.3977 ◽

2019 ◽

Vol 19 (1) ◽

pp. 70-77 ◽

Cited By ~ 2

Author(s):

Emil Tanghetti ◽

William Werschler ◽

Terry Lain ◽

Eric Guenin ◽

Gina Martin ◽

...

Keyword(s):

Acne Vulgaris ◽

Daily Treatment ◽

Phase 3 ◽

Two Phase ◽

Once Daily ◽

Severe Acne

Download Full-text

FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Efficacy and Safety From a Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.2.supp.56 ◽

2018 ◽

Vol 2 ◽

pp. S56 ◽

Cited By ~ 1

Author(s):

Joseph Raoof ◽

Deirdre Hooper ◽

Angela Moore ◽

Martin Zaiac ◽

Tory Sullivan ◽

...

Keyword(s):

Acne Vulgaris ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Severe Acne

Download Full-text

15202 A phase 3 study of 0.045% tazarotene lotion for once-daily treatment of moderate to severe acne vulgaris

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2020.06.664 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB144

Author(s):

Emil A. Tanghetti ◽

Edward Lain ◽

Lawrence J. Green ◽

Gina Martin ◽

Radhakrishnan (R.K.) Pillai ◽

...

Keyword(s):

Acne Vulgaris ◽

Daily Treatment ◽

Phase 3 ◽

Once Daily ◽

Severe Acne

Download Full-text

A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.08.020 ◽

2019 ◽

Vol 80 (1) ◽

pp. 168-177 ◽

Cited By ~ 8

Author(s):

Linda Stein Gold ◽

Sunil Dhawan ◽

Jonathan Weiss ◽

Zoe Diana Draelos ◽

Herman Ellman ◽

...

Keyword(s):

Acne Vulgaris ◽

Phase 3 ◽

Double Blind ◽

Severe Acne

Download Full-text

Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis

Journal of Drugs in Dermatology ◽

10.36849/jdd.2020.4869 ◽

2020 ◽

Vol 19 (3) ◽

pp. 272-279

Author(s):

Emil Tanghetti ◽

William Werschler ◽

Edward Lain ◽

Eric Guenin ◽

Susan Harris ◽

...

Keyword(s):

Phase 3 ◽

Once Daily ◽

Severe Acne

Download Full-text

Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males

Journal of Drugs in Dermatology ◽

10.36849/jdd.2020.3979 ◽

2019 ◽

Vol 19 (1) ◽

pp. 78-85 ◽

Cited By ~ 1

Author(s):

Fran Cook-Bolden ◽

Michael Gold ◽

Eric Guenin

Keyword(s):

Acne Vulgaris ◽

Daily Treatment ◽

Adult Males ◽

Once Daily ◽

Severe Acne

Download Full-text

153P Ramucirumab safety in East Asian (EA) compared to non-EA patients: A meta-analysis of adverse events (AEs) in 6 global, randomized, double-blind, phase 3 clinical trials

Annals of Oncology ◽

10.1016/s0923-7534(21)00311-2 ◽

2016 ◽

Vol 27 ◽

pp. ix47-ix48

Author(s):

H.C. Chung ◽

Y. Chao ◽

K.-W. Lee ◽

M. Kudo ◽

C.-J. Yen ◽

...

Keyword(s):

Clinical Trials ◽

Adverse Events ◽

Meta Analysis ◽

East Asian ◽

Phase 3 ◽

Double Blind

Download Full-text

Editorial Comment to Efficacy and safety of tadalafil 5 mg once‐daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double‐blind, parallel, placebo‐ and tamsulosin‐controlled study

International Journal of Urology ◽

10.1111/iju.13833 ◽

2018 ◽

Vol 26 (2) ◽

pp. 200-201

Author(s):

Takeya Kitta

Keyword(s):

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Asian Men ◽

Lower Urinary

Download Full-text

EFFICACY AND SAFETY OF LEFAMULIN VS MOXIFLOXACIN FOR ATYPICAL RESPIRATORY PATHOGENS IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: POOLED RESULTS FROM THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 DOUBLE-BLIND NONINFERIORITY PHASE-3 CLINICAL TRIALS

CHEST Journal ◽

10.1016/j.chest.2019.08.1035 ◽

2019 ◽

Vol 156 (4) ◽

pp. A1133-A1134

Author(s):

Andrew Shorr ◽

Jennifer Schranz ◽

Lisa Goldberg ◽

Susanne Paukner ◽

Elizabeth Alexander ◽

...

Keyword(s):

Clinical Trials ◽

Bacterial Pneumonia ◽

Respiratory Pathogens ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind

Download Full-text

Once-Daily Gastroretentive Gabapentin for Postherpetic Neuralgia: Integrated Efficacy, Time to Onset of Pain Relief and Safety Analyses of Data From Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies

Journal of Pain and Symptom Management ◽

10.1016/j.jpainsymman.2012.07.011 ◽

2013 ◽

Vol 46 (2) ◽

pp. 219-228 ◽

Cited By ~ 15

Author(s):

Richard L. Rauck ◽

Gordon A. Irving ◽

Mark S. Wallace ◽

Geertrui F. Vanhove ◽

Michael Sweeney

Keyword(s):

Pain Relief ◽

Postherpetic Neuralgia ◽

Phase 3 ◽

Two Phase ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Time To Onset

Download Full-text